Cipher Pharmaceuticals Second Quarter 2024 Earnings EPS Beats Expectations, Revenues Lag - Simply Wall St
| HLTRF Stock | USD 2.40 0.04 1.64% |
Roughly 62% of HLS Therapeutics' investor base is looking to short. The analysis of overall sentiment of trading HLS Therapeutics pink sheet suggests that many investors are alarmed at this time. The current market sentiment, together with HLS Therapeutics' historical and current headlines, can help investors time the market. In addition, many technical investors use HLS Therapeutics stock news signals to limit their universe of possible portfolio assets.
HLS Therapeutics pink sheet news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of HLS daily returns and investor perception about the current price of HLS Therapeutics as well as its diversification or hedging effects on your existing portfolios.
HLS |
Cipher Pharmaceuticals Second Quarter 2024 Earnings EPS Beats Expectations, Revenues Lag Simply Wall St
Read at news.google.com
 |
HLS Therapeutics Fundamental Analysis
We analyze HLS Therapeutics' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of HLS Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of HLS Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Book Value Per Share
Book Value Per Share Comparative Analysis
HLS Therapeutics is currently under evaluation in book value per share category among its peers. Book Value per Share (B/S) can be calculated by subtracting liabilities from assets, and then dividing it by the total number of currently outstanding shares. It indicates the level of safety associated with each common share after removing the effects of liabilities. In other words, a shareholder can use this ratio to see how much he or she can sell the stake in the company in the event of a liquidation.
HLS Therapeutics Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with HLS Therapeutics pink sheet to make a market-neutral strategy. Peer analysis of HLS Therapeutics could also be used in its relative valuation, which is a method of valuing HLS Therapeutics by comparing valuation metrics with similar companies.
Peers
HLS Therapeutics Related Equities
| BINP | Bionoid Pharma | 8.00 | ||||
| CRRTF | Crescita Therapeutics | 0.00 | ||||
| KHTRF | Knight Therapeutics | 0.53 | ||||
| LOVFF | Cannara Biotech | 9.09 |
Complementary Tools for HLS Pink Sheet analysis
When running HLS Therapeutics' price analysis, check to measure HLS Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy HLS Therapeutics is operating at the current time. Most of HLS Therapeutics' value examination focuses on studying past and present price action to predict the probability of HLS Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move HLS Therapeutics' price. Additionally, you may evaluate how the addition of HLS Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency |